|
|
|||||
| ALCL | RESEARCH GROUPS | FEATURED PUBLICATIONS | TOOLS | ||
The main task of the European Research Initiative on Anaplastic lymphoma kinase (ALK)-related malignancies (ERIA) is to strengthen cooperation and partnership of research groups focused on the role of ALK in cancer in order to accelerate scientific progress. With this aim in mind we anticipate that more efficacious and less toxic therapeutic strategies will be developed in the future through intense cooperation of involved partners.
| We are grateful to the British Association for Cancer Research (BACR) and Leukaemia and Lymphoma Research for their generous support. |   | Laboratory for Immunological and Molecular Cancer Research IIIrd Medical Department with Hematology, Medical Oncology, Hemostaseology, Rheumatology and Infectiology of the Paracelsus Medical University Salzburg Prof. Richard Greil |  |
| Université Paul Sabatier (Toulouse III) |  |
| CRCT - Le Centre de Recherches en Cancérologie de Toulouse |  |
Hospital S. Giovanni Battista |  |
| Campus IFOM-IEO Milano |  |
| Klinikum rechts der Isar der TU München III. Medizinische Klinik und Poliklinik |  |
| Medical University Vienna |  |
Charité Berlin |  |
| Paracelsus Medical University Salzburg | |
University of Oxford |  |
University of Cambridge |  |
Università degli Studi di Milano-Bicocca |  |